Acadia Pharmaceuticals Inc. ACAD
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing medicines for neurological disorders and rare diseases. The company’s primary purpose is to address conditions with significant unmet medical needs, particularly in central nervous system indications. Acadia’s commercia…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees796
TickerACAD
Statistics
Market Cap$3.69B
Revenue (TTM)$1.07B
Net Income$391.0M
Net Margin36.5%
EPS$2.30
P/E9.68
P/S3.34
P/B2.93
EV/EBITDA30.61
ROE37.3%
Dividend Yield—
Price$21.57
Data: Twelve Data · Revenue = mcap / P/S